Products for Research Use Only
RegisterLogin

Evofosfamide

CAT: 0013-GTR19171086-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19171086-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Evofosfamide (TH-302) is a hypoxia-activated prodrug that releases the DNA-crosslinking cytotoxin Br-IPM specifically in low-oxygen environments. Its selective activation under hypoxic conditions, a hallmark of solid tumors, makes it a valuable tool for investigating hypoxia-targeted therapies in both in vitro and in vivo cancer research models.
CAS Number
918633-87-1
Product Name Alternative
Apoptosis, Inhibitor, inhibit, Evofosfamide, Hypoxia-activated prodrug, TH302, TH-302, TH 302
Field of Research
Cell Biology
Purity
98.74% (May vary between batches)
Solubility
DMSO:83 mg/mL (184.84 mM) ; Ethanol:83 mg/mL (184.84 mM) ; H2O:10 mg/mL (22.27 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.35 mM)
Smiles
Cn1c (COP (=O) (NCCBr) NCCBr) cnc1[N+] ([O-]) =O
Molecular Formula
C9H16Br2N5O4P
Molecular Weight
449.04
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
MBS578482Evofosfamide
C08833-01Evofosfamide (TH-302)
MBS386293-01TH-302 (Evofosfamide)
A11144-500TH-302 (Evofosfamide) 500mg
A11144-1TH-302 (Evofosfamide) 1mg
A11144-25TH-302 (Evofosfamide) 25mg
A11144-10mM-DTH-302 (Evofosfamide) 10mM * 1mL in DMSO

Popular Products